Subarachnoid hemorrhage in the eighties: to treat or not to treat

被引:5
|
作者
Tacconi, Leonello [1 ]
Spinelli, Roberto [1 ]
Signorelli, Francesco [2 ]
机构
[1] Univ Hosp Trieste, Unit Neurosurg, Trieste, Italy
[2] Univ Bari Aldo Moro, Sch Med, Unit Neurosurg, Bari, Italy
关键词
Subarachnoid hemorrhage; Aneurysm; Aged; Surgical procedures; operative; Octogenarians; ELDERLY-PATIENTS; ENDOVASCULAR MANAGEMENT; CEREBRAL ANEURYSMS; NATURAL-HISTORY; AGE; PROGNOSIS; SURGERY;
D O I
10.23736/S0390-5616.19.04743-X
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Life expectancy has in the last few years increased and, as a consequence, also the number of elderly patients admitted to an Emergency Department with aneurysmal subarachnoid hemorrhage. We wanted to detect any difference in term of outcomes and adverse events between two groups of patients of different age, in relation to types of treatment and clinical status at presentation. METHODS: We selected and analyzed two groups of patients (group A and group B) among 458 retrospectively collected cases admitted to two neurosurgical centers with a diagnosis of aneurysmal subarachnoid hemorrhage over a 7.5-year period. Group A included 46 patients equal or older than 80 years and group B all the rest. Data were collected on age, sex, aneurysm location, size, comorbidities, clinical condition at presentation and at follow-up. RESULTS: In group A, 19 patients underwent surgery, 16 were embolized, 7 were treated conservatively and 4 died very soon after admission. After a median follow-up of 12 months 45.7% of patients had a good outcome, 24% were in poor conditions and 21.7% had died. When we compared these results with the youngest group, we found some important statistically significant differences. Older patients were more prone to have surgical and medical related complications, whereas endovascular treatment seemed to be a more sustainable treatment in the elderly age group. CONCLUSIONS: Elderly patients suffering from aneurysmal subarachnoid hemorrhage should be considered for treatment despite age, with endovascular embolization as the most preferable option. Without the treatment, the natural history can be very poor.
引用
收藏
页码:465 / 472
页数:8
相关论文
共 50 条
  • [41] TO TREAT OR NOT TO TREAT
    HOUPT, M
    JOURNAL OF THE AMERICAN DENTAL ASSOCIATION, 1990, 120 (04): : 378 - &
  • [42] To Treat or Not to Treat?
    Grovas-Cordovi, Esteban
    Rabell-Bernal, Andres
    Cepero-Jimenez, Carla M.
    Acosta-Pumarejo, Eduardo
    Santiago-Rivera, Loscar
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S858 - S858
  • [43] To treat or not to treat
    Bird, Sara
    AUSTRALIAN FAMILY PHYSICIAN, 2009, 38 (11) : 915 - 916
  • [44] To TREAT OR NOT TO TREAT
    Shabsigh, Ahmad
    JOURNAL OF MENS HEALTH, 2019, 15 (01) : E10 - E11
  • [45] To treat or not to treat?
    Edward H. Kaplan
    Nature Medicine, 1998, 4 : 664 - 665
  • [46] To Treat or Not to Treat
    Lee, Yeh Chen
    Davis, Alison
    JNCI CANCER SPECTRUM, 2019, 3 (02)
  • [47] Systolische Hypertonie—Treat or Not to Treat?Systolic Hypertension—Treat or Not to Treat?
    Elmar Offers
    Rainer E. Kolloch
    Herz, 2003, 28 (8) : 702 - 706
  • [48] Development of a Kit to Treat Subarachnoid Hemorrhage by Intrathecal Simple Urokinase Infusion (ITSUKI) Therapy: Preliminary Results in Patients with World Federation of Neurological Surgery (WFNS) Grade V Subarachnoid Hemorrhage
    Kai, Yutaka
    Ito, Koichi
    Watanabe, Masaki
    Morioka, Motohiro
    Yano, Shigetoshi
    Ohmori, Yuki
    Kawano, Takayuki
    Hamada, Jun-ichiro
    Kuratsu, Jun-ichi
    WORLD NEUROSURGERY, 2011, 75 (3-4) : 485 - 490
  • [49] To treat or not to treat: Intracranial hemorrhage, immune globulin effectiveness, and cost-effectiveness in pediatric ITP.
    Adams, JR
    Tarantino, MS
    DiLiberti, JH
    Bennett, CL
    BLOOD, 2001, 98 (11) : 863A - 863A
  • [50] Safety and efficacy of peripheral nerve blocks to treat refractory headaches after aneurysmal subarachnoid hemorrhage - A pilot observational study
    Rajagopalan, Swarna
    Siva, Nanda
    Novak, Andrew
    Garavaglia, Jeffrey
    Jelsema, Casey
    FRONTIERS IN NEUROLOGY, 2023, 14